CSI Market
Sign In | Register

Sangamo Therapeutics Inc (SGMO) Annual Balance Sheets

Annual · GAAP · USD millions
Access SGMO quarterly Balance Sheets →
Looking at balance sheet data from Sangamo Therapeutics Inc through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent20.95
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments20.00
Accounts receivable0.37
Income Taxes Receivable, Current NO10.14
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.37
Total Current Assets35.83
Equipment/Property/Plant Net11.04
Goodwill net0.00
Intangible Assets0.00
Long-term investments0.00
Income Taxes Receivable, Noncurrent8.94
Other Assets, Noncurrent3.94
Debt Securities Available For Sale Excluding Accrued Interest Current-
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset3.06
Total Assets59.75
Liabilities
Accounts Payable, Current AC14.44
Accrued Liabilities, Current AC9.41
Other Liabilities, Current18.62
Total Current Liabilities42.47
Total Long-term Debt0.00
Other liabilities, Noncurrent31.55
Contract With Customer Liability Current0.90
Contract With Customer Liability Noncurrent5.87
Operating Lease Liability Noncurrent25.09
Total Liabilities74.01
Stockholders' Equity
Common Stock Value3.51
Additional Paid In Capital Common Stock1,610.94
Retained Earnings / Accumulated Deficit-1,627.25
Other Equity-1.46
Common Stockholder's Equity-14.27
Total Stockholder's Equity-14.27
Liabilities & Stockholder's Equity59.75
4 historic quarters locked

Sign in to unlock the full Sangamo Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Sangamo Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-022029

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License